PMID- 34384417 OWN - NLM STAT- MEDLINE DCOM- 20220110 LR - 20220110 IS - 1472-6823 (Electronic) IS - 1472-6823 (Linking) VI - 21 IP - 1 DP - 2021 Aug 12 TI - Multiple endocrine neoplasia type 1 with a frameshift mutation in its gene accompanied by a giant cervical lipoma and multiple fatty deposits in the pancreas: case report. PG - 164 LID - 10.1186/s12902-021-00821-7 [doi] LID - 164 AB - BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is a syndrome characterized by pituitary neoplasia, primary hyperparathyroidism and pancreatic endocrine tumor. Here we show a case of MEN1 with a germline frameshift mutation in its gene accompanied by a giant cervical lipoma and multiple fatty deposits in the pancreas. CASE PRESENTATION: A 28-year-old man noticed the decreased visual acuity of both eyes and visited our institution. Since he was diagnosed as visual disturbance and brain computer tomography (CT) showed a mass in the pituitary fossa, he was hospitalized in our institution. Endoscopic trans-sphenoidal hypophysectomy and total parathyroidectomy with auto-transplantation were performed, and a giant cervical lipoma was resected. Furthermore, in genetic search, we found a germline frameshift mutation in MEN1 gene leading to the appearance of a new stop codon. CONCLUSIONS: We should bear in m ind that giant skin lipoma and multiple abnormal fatty deposits in the pancreas could be complicated with MEN1. CI - (c) 2021. The Author(s). FAU - Fushimi, Yoshiro AU - Fushimi Y AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Kamei, Shinji AU - Kamei S AD - Department of Diabetic Medicine, Kurashiki Central Hospital, Kurashiki, Japan. FAU - Tatsumi, Fuminori AU - Tatsumi F AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Sanada, Junpei AU - Sanada J AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Shimoda, Masashi AU - Shimoda M AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Kimura, Tomohiko AU - Kimura T AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Obata, Atsushi AU - Obata A AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Nakanishi, Shuhei AU - Nakanishi S AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Kaku, Kohei AU - Kaku K AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Mune, Tomoatsu AU - Mune T AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. FAU - Kaneto, Hideaki AU - Kaneto H AD - Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192, Kurashiki, Japan. kaneto@med.kawasaki-m.ac.jp. LA - eng PT - Case Reports PT - Journal Article DEP - 20210812 PL - England TA - BMC Endocr Disord JT - BMC endocrine disorders JID - 101088676 RN - 0 (MEN1 protein, human) RN - 0 (Proto-Oncogene Proteins) SB - IM MH - Adult MH - *Frameshift Mutation MH - Humans MH - Lipoma/complications/genetics/*pathology/surgery MH - Male MH - Multiple Endocrine Neoplasia Type 1/complications/genetics/*pathology/surgery MH - Pancreatic Diseases/complications/genetics/*pathology/surgery MH - Parathyroidectomy MH - Prognosis MH - Proto-Oncogene Proteins/*genetics PMC - PMC8359094 OTO - NOTNLM OT - A giant cervical lipoma OT - MEN1 OT - Multiple fatty deposits in the pancreas COIS- We do not have any potential conflicts of interest relevant to this article. EDAT- 2021/08/14 06:00 MHDA- 2022/01/11 06:00 PMCR- 2021/08/12 CRDT- 2021/08/13 05:38 PHST- 2021/05/11 00:00 [received] PHST- 2021/07/20 00:00 [accepted] PHST- 2021/08/13 05:38 [entrez] PHST- 2021/08/14 06:00 [pubmed] PHST- 2022/01/11 06:00 [medline] PHST- 2021/08/12 00:00 [pmc-release] AID - 10.1186/s12902-021-00821-7 [pii] AID - 821 [pii] AID - 10.1186/s12902-021-00821-7 [doi] PST - epublish SO - BMC Endocr Disord. 2021 Aug 12;21(1):164. doi: 10.1186/s12902-021-00821-7.